The multivariate analyses showed results consistent with our Kaplan–Meier survival estimates, indicating that high/moderate TGF-β1 expression increased the risk of death and tumor recurrence by 2.005- and 2.167-fold respectively compared to low TGF-β1 levels (Tables S2 and S3). This evidence concerns the gene TGFB1 and neoplasm.